Navigation Links
UW compound counters Avian flu

Madison, Wis. - Federal health officials may not be saying it, but they are frightened to death of the following scenario: an outbreak of the deadly avian flu virus begins quietly in scattered areas of the country, and spreads before they can get a handle on it - with substantial harm done to public health and the economy.

It's not an irrational fear, and one that is exacerbated by......

Full article >>> nology, would like to quickly move the research into the preclinical phase. The road ahead includes deciphering the peptide's precise mechanism for frustrating the flu, and work to determine optimal dosage, efficacy, and safety before the drug can be tested in humans.

Brandt's projected timetable is even longer. "If we had the funding now to start pre-clinical trials, we would be 4 to 5 y......

Full article >>>
At the moment, there are a few flu-fighting antiviral medications on the market, and they have worked either by preventing virus replication within the cell, or preventing the release of viruses from the cell. They are, however, beginning to lose their effectiveness, which has health professionals worried that the flu virus, including deadly strains like H5N1, will evolve to the point where ......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 10/04/06


Related biology technology :

1. TSKgel ODS-100Z and TSKgel ODS-100V column series provides a universal solution for the analysis of samples containing acidic, basic, polar & non-polar compounds
2. Third Wave files countersuit vs. Digene in patent case
3. Genomic DNA Isolation Protocol for 40 l Avian Whole Blood
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... 23, 2016 , ... Charm Sciences, Inc. is pleased to ... AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of the ... Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):